These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HES1 activation suppresses proliferation of leukemia cells in acute myeloid leukemia. Tian C; Yu Y; Jia Y; Zhu L; Zhang Y Ann Hematol; 2015 Sep; 94(9):1477-83. PubMed ID: 26092281 [TBL] [Abstract][Full Text] [Related]
4. Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppression. Kannan S; Fang W; Song G; Mullighan CG; Hammitt R; McMurray J; Zweidler-McKay PA Blood; 2011 Mar; 117(10):2891-900. PubMed ID: 21224467 [TBL] [Abstract][Full Text] [Related]
5. Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein. Li GH; Fan YZ; Liu XW; Zhang BF; Yin DD; He F; Huang SY; Kang ZJ; Xu H; Liu Q; Wu YL; Niu XL; Zhang L; Liu L; Hao MW; Han H; Liang YM Mol Cell Biochem; 2010 Jul; 340(1-2):7-14. PubMed ID: 20157766 [TBL] [Abstract][Full Text] [Related]
7. EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid Leukemia. Bill M; Pathmanathan A; Karunasiri M; Shen C; Burke MH; Ranganathan P; Papaioannou D; Zitzer NC; Snyder K; LaRocco A; Walker AE; Brannan ZJ; Nalin AP; Freud AG; Dikov MM; Zhang X; Bloomfield CD; Garzon R; Dorrance AM Clin Cancer Res; 2020 Feb; 26(3):669-678. PubMed ID: 31672772 [TBL] [Abstract][Full Text] [Related]
8. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines. Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102 [TBL] [Abstract][Full Text] [Related]
9. A study on Notch signaling in human breast cancer. Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320 [TBL] [Abstract][Full Text] [Related]
10. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway. Lee JH; Suk J; Park J; Kim SB; Kwak SS; Kim JW; Lee CH; Byun B; Ahn JK; Joe CO Mol Cancer Res; 2009 Oct; 7(10):1663-71. PubMed ID: 19808903 [TBL] [Abstract][Full Text] [Related]
11. Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma. Teider N; Scott DK; Neiss A; Weeraratne SD; Amani VM; Wang Y; Marquez VE; Cho YJ; Pomeroy SL Neuro Oncol; 2010 Dec; 12(12):1244-56. PubMed ID: 20847082 [TBL] [Abstract][Full Text] [Related]
12. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568 [TBL] [Abstract][Full Text] [Related]
13. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
14. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056 [TBL] [Abstract][Full Text] [Related]
15. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. Espinosa L; Cathelin S; D'Altri T; Trimarchi T; Statnikov A; Guiu J; Rodilla V; Inglés-Esteve J; Nomdedeu J; Bellosillo B; Besses C; Abdel-Wahab O; Kucine N; Sun SC; Song G; Mullighan CC; Levine RL; Rajewsky K; Aifantis I; Bigas A Cancer Cell; 2010 Sep; 18(3):268-81. PubMed ID: 20832754 [TBL] [Abstract][Full Text] [Related]
16. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis. Peignon G; Durand A; Cacheux W; Ayrault O; Terris B; Laurent-Puig P; Shroyer NF; Van Seuningen I; Honjo T; Perret C; Romagnolo B Gut; 2011 Feb; 60(2):166-76. PubMed ID: 21205878 [TBL] [Abstract][Full Text] [Related]
17. Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells. Lee JB; Werbowetski-Ogilvie TE; Lee JH; McIntyre BA; Schnerch A; Hong SH; Park IH; Daley GQ; Bernstein ID; Bhatia M Blood; 2013 Aug; 122(7):1162-73. PubMed ID: 23733337 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway. Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207 [TBL] [Abstract][Full Text] [Related]
19. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Yu X; Alder JK; Chun JH; Friedman AD; Heimfeld S; Cheng L; Civin CI Stem Cells; 2006 Apr; 24(4):876-88. PubMed ID: 16513761 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effects of the Notch pathway in gastrointestinal stromal tumors. Dumont AG; Yang Y; Reynoso D; Katz D; Trent JC; Hughes DP Carcinogenesis; 2012 Sep; 33(9):1674-83. PubMed ID: 22764137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]